Journal Article DKFZ-2026-01577

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
A translational journey in Germany: From literature to local implementation of [89Zr]Zr-DFO-trastuzumab. [Eine translationale Reise in Deutschland: von der Literaturrecherche bis zur lokalen Etablierung von [89Zr]Zr-DFO-trastuzumab.]

 ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;

2026
Thieme Stuttgart

Nuklearmedizin nn, nn () [10.1055/a-2883-7600]
 GO

Abstract: [⁸⁹Zr]Zr-DFO-trastuzumab has emerged as a powerful tool to visualise non-invasively HER2 expression across metastatic lesions, complementing conventional pathological HER2 evaluation and helping to identify patients unlikely to benefit from therapy with trastuzumab-based therapies. This paper outlines the roadmap of the manufacturing implementation of [89Zr]Zr-DFO-trastuzumab at our centre in Germany.In this paper, we describe the key questions encountered during implementation of the manufacturing process for [89Zr]Zr-DFO-trastuzumab and how these were addressed through discussions between academia, hospital departments, teams experienced in the radiolabelling of antibodies and regulatory authorities.Discussions with multiple institutions were essential for the implementation of the GMP-compliant radiosynthesis of [⁸⁹Zr]Zr-DFO-trastuzumab at our manufacturing site. Example decisions included shortening the shelf-life of [⁸⁹Zr]Zr-DFO-trastuzumab to 24 hours to mitigate container-closure integrity concerns and adoption of a bead-based method to determine the immunoreactive fraction.This work presents a practical overview of operational considerations relevant to the clinical implementation of [⁸⁹Zr]Zr-DFO-trastuzumab, with potential applicability to other ⁸⁹Zr-labelled high-molecular-weight radiotracers in Germany. By sharing these practical insights, we aim to support broader patient access to established radiopharmaceuticals and encourage dialogue around open regulatory and practical questions, particularly in anticipation of future clinical trials.

Classification:

Note: #NCTZFB26# / epub

Contributing Institute(s):
  1. Koordinierungsstelle NCT Dresden (DD04)
  2. Translationale Bildgebung in der Onkologie (DD12)
Research Program(s):
  1. 899 - ohne Topic (POF4-899) (POF4-899)

Appears in the scientific report 2026
Database coverage:
Medline ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; Essential Science Indicators ; IF < 5 ; JCR ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Document types > Articles > Journal Article
Public records
Publications database

 Record created 2026-06-29, last modified 2026-06-30



Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)